Plus therapeutics provides updates on respect™ clinical trials at the 27th annual scientific meeting and education day of the society for neuro-oncology

Respect-gbm clinical trial of rhenium ( 186 re) obisbemeda in recurrent glioblastoma continues to demonstrate safety and overall survival correlates with radiation dose to tumor

PSTV Ratings Summary

PSTV Quant Ranking